Provided by Tiger Trade Technology Pte. Ltd.

Vanguard Health Care ETF

315.31
+2.430.78%
Post-market: 315.310.00000.00%19:46 EDT
Volume:370.00K
Turnover:117.09M
Market Cap:18.97B
PE:34.23
High:318.31
Open:313.66
Low:313.41
Close:312.88
52wk High:330.75
52wk Low:263.00
Shares:60.18M
Float Shares:60.18M
Volume Ratio:1.79
T/O Rate:0.61%
Dividend:4.63
Dividend Rate:1.47%
EPS(TTM):9.21
EPS(LYR):41.51
ROE:3.75%
ROA:0.89%
PB:0.96
PE(LYR):7.60

Loading ...

Health Care up on Defensive Bias

Dow Jones
·
5 hours ago

3 ‘Strong Buy’ Dividend Aristocrat Stocks on Analysts’ Watch List

TIPRANKS
·
5 hours ago

Estee Lauder Cos. Cl a Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
6 hours ago

Eli Lilly & Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
6 hours ago

Clover Health to Report Third Quarter 2026 Financial Results on November 4, 2026

GlobeNewswire
·
6 hours ago

Principal Technologies to Settle Over $534,000 in Debt Through Share Issuance

TIPRANKS
·
7 hours ago

Sector Update: Healthcare

MT Newswires Live
·
9 hours ago

Exchange-Traded Funds Lower as US Equities Decline After Midday

MT Newswires Live
·
9 hours ago

Moderna, Merck Climb on Collaboration with Tempus

Reuters
·
10 hours ago

Merck's Keytruda is Dealt a Legal Setback. It's Good News for This Biotech Stock.

Dow Jones
·
10 hours ago

Eli Lilly and Co Stock (LLY) Moved Up by 3.94% on Oct 7: Facts Behind the Movement

TradingKey
·
10 hours ago

Amgen Inc Stock (AMGN) Moved Up by 3.06% on Oct 7: A Full Analysis

TradingKey
·
10 hours ago

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
10 hours ago

Pharma Lobby Sues Trump Administration over Medicare Drug Price Cuts

Reuters
·
Yesterday

Eli Lilly is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Yesterday

What Eli Lilly Stock's First Line Jaypirca Approval Means For Shareholders

Simply Wall St.
·
Yesterday

Halozyme Therapeutics Shares up 2% After Court Win Against Merck to Block Subcutaneous Keytruda in Select Markets

THOMSON REUTERS
·
Yesterday

Micro-Cap Stock Veraxa Biotech is Down 96% This Year. Can Next-Gen Drug Testing Save It?

Dow Jones
·
Yesterday

Morgan Stanley Adjusts Price Target on Merck to $177 From $179

MT Newswires Live
·
Yesterday

AbbVie’s telisotuzumab adizutecan gets two FDA Breakthrough Therapy Designations

TIPRANKS
·
Yesterday